Literature DB >> 11403943

Predominant functional activity of the large, neutral amino acid transporter (LAT1) isoform at the cerebrovasculature.

D M Killian1, P J Chikhale.   

Abstract

In this study, we identify the predominant functional expression of the large, neutral amino acid transporter (LAT1) isoform at the blood-brain barrier (BBB). An in situ rat brain perfusion technique allowed perfusion of the radiotracer [(14)C]-L-Leu (a ligand for both LAT1 and LAT2) alone or competed with excess concentration of either LAT1 or LAT2 specific amino acids. The LAT2 specific amino acid, [(14)C]-L-Asn, was perfused alone or with excess concentration of various amino acids. The brain uptake of [(14)C]-L-Leu was not significantly inhibited by LAT2 specific amino acids, but was inhibited significantly (up to 90%) by the LAT1 specific amino acid, D-Met. L-Asn did not demonstrate saturable brain uptake. These data clearly demonstrate that LAT1 is the functionally predominant isoform expressed at the BBB which is responsible for brain uptake of large, neutral amino acids. In addition, the functional activity of cerebrovascular LAT2 is insignificant, or absent.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403943     DOI: 10.1016/s0304-3940(01)01810-9

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  27 in total

1.  Coadministration of branched-chain amino acids and lipopolysaccharide causes matrix metalloproteinase activation and blood-brain barrier breakdown.

Authors:  Giselli Scaini; Meline O S Morais; Leticia S Galant; Francieli Vuolo; Dhébora M Dall'Igna; Matheus A B Pasquali; Vitor M Ramos; Daniel P Gelain; Jose Claudio F Moreira; Patrícia F Schuck; Gustavo C Ferreira; Francisco G Soriano; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2014-01-05       Impact factor: 5.590

2.  The methylmercury-L-cysteine conjugate is a substrate for the L-type large neutral amino acid transporter.

Authors:  Zhaobao Yin; Haiyan Jiang; Tore Syversen; João B T Rocha; Marcelo Farina; Michael Aschner
Journal:  J Neurochem       Date:  2008-09-13       Impact factor: 5.372

Review 3.  SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.

Authors:  Marilyn E Morris; Vivian Rodriguez-Cruz; Melanie A Felmlee
Journal:  AAPS J       Date:  2017-06-29       Impact factor: 4.009

4.  Effect of α-Methyl versus α-Hydrogen Substitution on Brain Availability and Tumor Imaging Properties of Heptanoic [F-18]Fluoroalkyl Amino Acids for Positron Emission Tomography (PET).

Authors:  Ahlem Bouhlel; Wadha Alyami; Aixiao Li; Liya Yuan; Keith Rich; Jonathan McConathy
Journal:  J Med Chem       Date:  2016-03-23       Impact factor: 7.446

Review 5.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

Review 6.  "Classical organic acidurias": diagnosis and pathogenesis.

Authors:  Guglielmo Rd Villani; Giovanna Gallo; Emanuela Scolamiero; Francesco Salvatore; Margherita Ruoppolo
Journal:  Clin Exp Med       Date:  2016-09-09       Impact factor: 3.984

7.  Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.

Authors:  T Kato; J Shinoda; N Oka; K Miwa; N Nakayama; H Yano; T Maruyama; Y Muragaki; T Iwama
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-07       Impact factor: 3.825

8.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

9.  Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.

Authors:  Tracey A Simmons-Willis; Albert S Koh; Thomas W Clarkson; Nazzareno Ballatori
Journal:  Biochem J       Date:  2002-10-01       Impact factor: 3.857

10.  Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.

Authors:  William J Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J Skvorak; Harbhajan S Paul; Gregg E Homanics; Maria C Bewley; Keith C Cheng; Kathryn F Lanoue; John M Flanagan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.